These results suggest that the expression of ACSL4 negatively controlled the expression of ER and may be one of the first events in the transformation of the ER and PR positive phenotype into negative one as shown for the MDA-MD-231 human breast tumor xenograft. The gene discussed is ACSL4; the disease is breast neoplasm.